Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2007
11/29/2007US20070276022 Optically Active Carboxamides
11/29/2007US20070276020 Dicationic Compounds For Activity Against Trichomonas Vaginalis
11/29/2007US20070276011 Plasminogen Activator Inhibitor-1 Inhibitor
11/29/2007US20070276010 benzyl-carbamic acid cis-3-[5-(cyclohexanecarbonyl-amino)-1H-pyrazol-3-yl]-cyclobutyl ester; glycogen synthase kinase-3 (GSK-3) inhibitors; inter alia, Alzheimer's Disease, cancer, dementia, depression, diabetes, hair loss, schizophrenia, and stroke
11/29/2007US20070276005 Tri-substitued 2-benzhydryl 5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6 disubstituted pyran derivatives
11/29/2007US20070276003 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma
11/29/2007US20070275962 Heterobicyclic Compounds as Pharmaceutically Active Agents
11/29/2007US20070275960 Phenyl and pyridyl compounds for inflammation and immune-related uses
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007US20070275954 Novel Fused Heterocycles and Uses Thereof
11/29/2007US20070275953 2-Pyridinone Derivatives, Having Hiv Inhibiting Properties
11/29/2007US20070275858 Substituted spirocyclic ketoenols
11/29/2007US20070272920 Metal quinolate, in particular lithium quinolate, and an electroluminescent organometallic thianthrene ligand complex; displays in video displays, mobile telephones, portable computers
11/29/2007DE102006024024A1 Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung Substituted Arylimidazolone and -triazolone and their use
11/29/2007CA2652440A1 Composition for diagnosis of amyloid-related disease
11/29/2007CA2652152A1 Process for preparing 7-(acryloyl)indoles
11/29/2007CA2649913A1 N-benzoyl- and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
11/28/2007EP1858890A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments
11/28/2007EP1858888A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/28/2007EP1858860A1 Phthalazinones
11/28/2007EP1858592A2 Treatment of inflammatory bowel disease
11/28/2007EP1725543B1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/28/2007EP1534674A4 Cytotoxic agents containing novel potent taxanes and their therapeutic use
11/28/2007EP1425275B1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, and process for dna hybridizatioon detection using the polymer
11/28/2007CN101080396A Quinoxalines as B Raf inhibitors
11/28/2007CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/28/2007CN100351239C Pyrimidine derivatives and their use as CB2 modulators
11/28/2007CN100351237C Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
11/28/2007CN100351236C 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
11/28/2007CN100351230C Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester
11/27/2007US7301037 Charged compounds comprising a nucleic acid binding moiety and uses therefor
11/27/2007US7301022 N-(2-(6-7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-ylamino)pyrimidin-4-yl)-5-(trifluoromethyl)phenyl)-1-isopropylpyrrolidine-2-carboxamide hydrochloride; antiinflammatory agents, analgesics, antiarthritic agents, antiulcer agents
11/27/2007US7300950 Pyrazole derivatives, their preparation and their use in pharmaceuticals
11/27/2007US7300945 For therapy of of certain central nervous system (CNS) diseases, anxiety, depression, a sleep disorder, schizophrenia, or attention deficit-hyperactivity disorder
11/27/2007US7300941 Non-imidazole compounds
11/27/2007US7300937 Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
11/27/2007US7300933 Diazabicyclic biaryl derivatives
11/22/2007WO2007133622A2 Selective inhibitors of rock protein kinase and uses thereof
11/22/2007WO2007133491A1 Substituted spirocyclic cgrp receptor antagonists
11/22/2007WO2007132945A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132906A1 Benzylamine derivatives as cetp inhibitors
11/22/2007WO2007132475A1 Selective tr-beta 1 agonist
11/22/2007WO2007132010A1 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors
11/22/2007WO2007131764A2 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007WO2007131366A1 Iap bir domain binding compounds
11/22/2007WO2007105989A3 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
11/22/2007WO2007095495A3 Benzodiazepine gcnf modulators for stem cell modulation
11/22/2007WO2007089669A3 Processes for the preparation of compounds which modulate cell proliferation
11/22/2007WO2007075783A3 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor
11/22/2007WO2007050802A3 Novel opioid antagonists
11/22/2007WO2006135839A3 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor
11/22/2007WO2005117543A3 N-sulfonylcarboximidamide apoptosis promoters
11/22/2007WO2005046589A3 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
11/22/2007US20070270594 catalytic synthesis of 4,5-Dichloro-thiophene-2-sulfonic acid [(E)-3-[1-(2,4-dichlorophenylmethyl)-5-fluoro-3-methyl-1H-indol-7-yl]-acryloyl]amide; antagonists of the EP3 receptor for prostaglandin E2; atherosclerosis, myocardial infarction and peripheral arterial occlusive disease
11/22/2007US20070270482 Cytotoxic Agents Comprising New C-2 Modified Taxanes
11/22/2007US20070270478 e.g. 3-[4-(3,5-bis-trifluoromethyl-pyrazol-1-yl)-phenyl]-2-(2,3-difluoro-phenyl)-acrylonitrile; immunosuppressant; bioavailability; side effect reduction; interleukin-2 inhibitor
11/22/2007US20070270474 Pyrazole compounds for treatment of neurodegenerative disorders
11/22/2007US20070270470 N-[[4-(4-bromophenyl)-5-(2,4-dichlorophenyl)-3-methyl-2-thienyl]methyl]-2-ethylbutanamide; cannabinoid CB1 receptor antagonists
11/22/2007US20070270466 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists
11/22/2007US20070270464 Prodrugs of curcumin analogs
11/22/2007US20070270460 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270395 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 2-Cyclopropylmethoxy-4-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
11/22/2007US20070267968 Electronic devices made with electron transport and/or anti-quenching layers
11/22/2007CA2652455A1 Iap bir domain binding compounds
11/22/2007CA2652101A1 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007CA2651836A1 Selective inhibitors of rock protein kinase and uses thereof
11/22/2007CA2650515A1 Benzylamine derivatives as cetp inhibitors
11/22/2007CA2647238A1 2,4-diamino pyrimidines as cell cycle kinase inhibitors
11/21/2007EP1857455A1 Cinnamoyl compound and use thereof
11/21/2007EP1856112A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/21/2007EP1856099A2 Acridine and quinoline derivatives as sirtuin modulators
11/21/2007EP1856083A2 Chromen-4-one inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
11/21/2007EP1856082A1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
11/21/2007EP1856058A2 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
11/21/2007EP1856049A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/21/2007EP1856042A2 Substituted gamma lactams as therapeutic agents
11/21/2007EP1761524B1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists
11/21/2007EP1663982B1 Aminoquinoline derivatives and their use as adenosine a3 ligands
11/21/2007EP1578425B1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007CN101076529A Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease
11/21/2007CN101074208A Production of indole derivative
11/21/2007CN100349888C Medicine compound
11/20/2007US7297797 5-(2,6-difluorophenyl)-2-[4'-(5-ethoxy-2-thienyl)-1,1'-biphenyl-4-yl]-3,4-dihydro-2H-pyrrole; pesticide
11/20/2007US7297706 Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders
11/20/2007US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/20/2007US7297693 furan-, pyrrole- or thiophenecarboxamides ring-substituted with a hydroxyimino-fused ring and a nitrogen heteroarene; e.g., 5-[5-(1-Morpholin-4-yl-methanoyl)-2-pyridin-4-yl-furan-3-yl]-indan-1-one oxime;treating neurotraumatic diseases, cancer, neurodegeneration, pain, migraine and cardiac hypertrophy
11/20/2007CA2125236C Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives
11/15/2007WO2007131179A1 Factor xa inhibitors
11/15/2007WO2007129745A1 Heteroarylamide lower carboxylic acid derivative
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007128454A1 3-tetrazolyl indazoles, 3-tetrazolyl pyrazolopyridines, and use thereof
11/15/2007WO2007128410A1 Insecticidal compounds
11/15/2007WO2007109578A3 Substituted gamma lactams as prostaglandin ep2 agonists
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 523